ProfileGDS4718 / 218303_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 97% 98% 94% 97% 98% 94% 90% 98% 97% 98% 98% 98% 96% 93% 95% 96% 98% 96% 95% 96% 98% 98% 98% 97% 98% 94% 97% 95% 98% 95% 97% 93% 98% 98% 92% 90% 96% 97% 97% 93% 98% 96% 95% 94% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]11.187797
GSM549102patient 115, normal, homogenized [OPG study]11.458698
GSM549104patient 119, normal, homogenized [OPG study]9.9382594
GSM549108patient 138, normal, homogenized [OPG study]10.881297
GSM549119patient 077, normal, homogenized [OPG study]11.558798
GSM549133patient 032, cancer, homogenized [OPG study]10.120694
GSM549139patient 042, cancer, homogenized [OPG study]9.2343590
GSM549099patient 107, normal, homogenized [OPG study]11.408198
GSM549109patient 139, normal, homogenized [OPG study]11.13597
GSM549110patient 046, normal, homogenized [OPG study]11.894298
GSM549114patient 063, normal, homogenized [OPG study]11.803698
GSM549122patient 082, normal, homogenized [OPG study]11.434698
GSM549134patient 033, cancer, homogenized [OPG study]10.638396
GSM549136patient 036, cancer, homogenized [OPG study]9.7783193
GSM549140patient 044, cancer, homogenized [OPG study]10.267495
GSM549111patient 047, normal, homogenized [OPG study]10.806596
GSM549113patient 057, normal, homogenized [OPG study]11.669398
GSM549132patient 031, cancer, homogenized [OPG study]10.389596
GSM549137patient 038, cancer, homogenized [OPG study]10.129795
GSM549142patient 047, cancer, homogenized [OPG study]10.079396
GSM549100patient 110, normal, homogenized [OPG study]11.590998
GSM549107patient 135, normal, homogenized [OPG study]11.634298
GSM549115patient 068, normal, homogenized [OPG study]11.542898
GSM549116patient 072, normal, homogenized [OPG study]11.127797
GSM549120patient 078, normal, homogenized [OPG study]11.751398
GSM549131patient 030, cancer, homogenized [OPG study]9.9658194
GSM549118patient 074, normal, homogenized [OPG study]10.903197
GSM549129patient 027, cancer, homogenized [OPG study]9.9543995
GSM549123patient 088, normal, homogenized [OPG study]11.668398
GSM549124patient 006, cancer, homogenized [OPG study]9.9198995
GSM549126patient 015, cancer, homogenized [OPG study]10.704597
GSM549128patient 025, cancer, homogenized [OPG study]9.6254893
GSM549103patient 117, normal, homogenized [OPG study]11.318798
GSM549117patient 073, normal, homogenized [OPG study]11.751898
GSM549138patient 041, cancer, homogenized [OPG study]9.4709392
GSM549141patient 045, cancer, homogenized [OPG study]9.3158890
GSM549130patient 028, cancer, homogenized [OPG study]10.341396
GSM549101patient 111, normal, homogenized [OPG study]11.050797
GSM549105patient 128, normal, homogenized [OPG study]11.065597
GSM549106patient 134, normal, homogenized [OPG study]10.004493
GSM549112patient 048, normal, homogenized [OPG study]11.610298
GSM549125patient 011, cancer, homogenized [OPG study]10.3396
GSM549127patient 024, cancer, homogenized [OPG study]10.04395
GSM549135patient 035, cancer, homogenized [OPG study]10.081994